Journal of Commercial Biotechnology

Editorial
pp. 253-253(1)
Author: Henderson, Neil

Valuing biotechnology companies using the price earnings ratio
pp. 254-260(7)
Authors: Loh, Jacqueline; Brooks, Robert

An overview of trends in multilateral environmental agreements with an impact on biotechnology and research in Asia and the Pacific
pp. 261-273(13)
Authors: Keller, Frankie; Macer, Darryl R J

What you give is what you get: Investment in European biotechnology
pp. 274-283(10)
Author: Bains, William

Ticking time bomb: Poorly managed product safety
pp. 284-293(10)
Authors: Meline, Greg; Albani, Chris

Cancer remains the dominant disease target for biotech through to 2010
pp. 294-298(5)
Authors: Pijpers, Fleur; Belsey, Mark J

Legal and regulatory update
pp. 299-311(13)